[CLDX] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -62.51%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 4,651 7,418 3,573 9,538 12,743 6,786 5,480 -2.69%
PBT -70,738 -60,947 -50,878 -151,949 -117,313 -128,530 -127,197 -9.30%
Tax -227 -1,167 -506 -765 -24,282 -8,772 -2,344 -32.21%
NP -70,511 -59,780 -50,372 -151,184 -93,031 -128,530 -127,197 -9.35%
Tax Rate - - - - - - - -
Total Cost 75,162 67,198 53,945 160,722 105,774 135,316 132,677 -9.02%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -1,516.04 -805.88 -1,409.80 -1,585.07 -730.06 -1,894.05 -2,321.11 -6.84%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -1.64 -2.02 -3.47 -14.48 -10.86 -18.99 -19.66 -33.87%
EPS Diluted -1.64 -2.02 -3.47 -14.48 -10.86 -18.99 -19.66 -33.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.